HCPLive

Sleep Restriction Affects Respiratory, Vascular Control

FRIDAY, April 26 (HealthDay News) -- Partial sleep deprivation leads to less healthy vascular function and impaired breathing control, according to a study presented at Experimental Biology 2013, held from April 20 to 24 in Boston.

Keith Pugh, from the University of Birmingham, in the United Kingdom, and colleagues assessed chemosensitivity and endothelial function (measured by flow-mediated dilation) in eight participants assigned to either a sleep restriction protocol consisting of a baseline night of eight hours sleep, followed by three nights of four hours sleep, or a control protocol consisting of the same initial night followed by three nights of 10 hours of sleep opportunity.

The researchers found that, in the sleep restriction group, central chemosensitivity increased by 51.6 ± 9.4 percent after the second night of sleep restriction but returned to baseline after the third night. Central chemosensitivity remained unchanged in the control group. There was no difference in peripheral chemosensitivity between the two protocols. After the second night of sleep restriction, endothelial function decreased by 46.7 ± 1.6 percent but recovered after the third night. The control group did not experience changes in endothelial function.

"If acute sleep loss occurs repetitively over a long period of time, then vascular health could be compromised further and eventually mediate the development of cardiovascular disease," Pugh said in a statement.

Press Release
More Information

Copyright © 2013 HealthDay. All rights reserved.

Most Popular

Recommended Reading

Click here to read the statement of need, learning objectives, instructions on how to obtain CME credit, faculty list and disclosures, and other information for this activity.
Click here to review the CME questions for this month's issue.
As the use of long-term opioid therapy to treat chronic pain continues to be a hotly debated topic, a new study in PAIN analyzed the extent to which patients misuse their medications and the risk of addiction associated with these behaviors.
By using genetically modified corn, researchers are another step closer to an oral vaccine for hepatitis B, a virus that has infected almost two billion people worldwide.
$vAR$